• (PLX AI) – BioMerieux half year adjusted EBIT EUR 374 million vs. estimate EUR 312 million.
  • • Half year revenue EUR 1,574 million vs. estimate EUR 1,553 million
  • • Confirms its annual guidance of organic sales growth at neutral to mid-single digit rate and contributive operating income before non-recurring items in line with 2020

Quelle: PLX AI